Titel

Merkliste
1 Ergebnisse

Supplemental Table 2. Activity of ASO targeting RBD or BCL-..:

Figshare Future Science Group (6457551) ; Robert K. DeLong (3745879) ; Ryan Swanson (8333802)...
https://figshare.com/articles/dataset/Supplemental_Table_2_Activity_of_ASO_targeting_RBD_or_BCL-xL_in_B16F10_A375_and_132N1_cells/15042828. , 2021

Link: https://doi.org/10.25402/nnm.15042828.v1

RT Journal
T1 <Title>Supplemental Table 2. Activity of ASO targeting RBD or BCL-xL in B16F10, A375 and 132N1 cells</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_15042828&Exemplar=1&LAN=DE
				
A1 Figshare Future Science Group (6457551)
A1 Robert K. DeLong (3745879)
A1 Ryan Swanson (8333802)
A1 Megan C. Niederwerder (4984718)
A1 Pratiksha Khanal (11176347)
A1 Santosh Aryal (1330296)
A1 Ramesh Marasini (11176350)
A1 Majid Jaberi-Douraki (9021827)
A1 Heman Shakeri (11176353)
A1 Reza Mazloom (10619384)
A1 Sarah Schneider (3606071)
A1 Steve Ensley (9360938)
A1 Lane L. Clarke (11176356)
A1 Rowena A. Woode (11176359)
A1 Sarah Young (6776360)
A1 Sagar Rayamajhi (11176362)
A1 Tracy Miesner (432943)
A1 Mary Lynn Higginbotham (9266090)
A1 Zhoumeng Lin (2399779)
A1 Tej Shrestha Kartik Ghosh (11176365)
A1 Garry Glaspell (2648533)
A1 Elza N. Mathew (5305013)
YR 2021
K1 Infectious Diseases
K1 Cancer Therapy (excl. Chemotherapy and Radiation Therapy)
K1 Toxicology (incl. Clinical Toxicology)
K1 Nanomedicine
K1 Anticancer activity
K1 Antiviral activity
K1 Peptide delivery
K1 Antisense oligomer delivery
K1 Aptamer delivery
JF https://figshare.com/articles/dataset/Supplemental_Table_2_Activity_of_ASO_targeting_RBD_or_BCL-xL_in_B16F10_A375_and_132N1_cells/15042828
LK http://dx.doi.org/https://doi.org/10.25402/nnm.15042828.v1
DO https://doi.org/10.25402/nnm.15042828.v1
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)